Review




Structured Review

MetaMorph Inc integrative morphometry analysis
Integrative Morphometry Analysis, supplied by MetaMorph Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/integrative morphometry analysis/product/MetaMorph Inc
Average 90 stars, based on 1 article reviews
integrative morphometry analysis - by Bioz Stars, 2026-04
90/100 stars

Images



Similar Products

99
LI-COR od ysse y infr ar ed ima ging system
Od Ysse Y Infr Ar Ed Ima Ging System, supplied by LI-COR, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/od ysse y infr ar ed ima ging system/product/LI-COR
Average 99 stars, based on 1 article reviews
od ysse y infr ar ed ima ging system - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

96
Selleck Chemicals imatinib mesylate ima
Imatinib Mesylate Ima, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/imatinib mesylate ima/product/Selleck Chemicals
Average 96 stars, based on 1 article reviews
imatinib mesylate ima - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

93
Cusabio human ima elisa
Human Ima Elisa, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ima elisa/product/Cusabio
Average 93 stars, based on 1 article reviews
human ima elisa - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology ima
Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B <t>)</t> <t>K562R-ima,</t> and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).
Ima, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ima/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
ima - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
MetaMorph Inc integrative morphometry analysis
Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B <t>)</t> <t>K562R-ima,</t> and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).
Integrative Morphometry Analysis, supplied by MetaMorph Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/integrative morphometry analysis/product/MetaMorph Inc
Average 90 stars, based on 1 article reviews
integrative morphometry analysis - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

99
Nikon ima system
Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B <t>)</t> <t>K562R-ima,</t> and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).
Ima System, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ima system/product/Nikon
Average 99 stars, based on 1 article reviews
ima system - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

99
Thermo Fisher mold agar ima media
Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B <t>)</t> <t>K562R-ima,</t> and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).
Mold Agar Ima Media, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mold agar ima media/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
mold agar ima media - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

90
Musashi Engineering Inc musashi ima
Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B <t>)</t> <t>K562R-ima,</t> and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).
Musashi Ima, supplied by Musashi Engineering Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/musashi ima/product/Musashi Engineering Inc
Average 90 stars, based on 1 article reviews
musashi ima - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Hexcel Corporation m21/ud194/ima unidirectional prepreg
Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B <t>)</t> <t>K562R-ima,</t> and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).
M21/Ud194/Ima Unidirectional Prepreg, supplied by Hexcel Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m21/ud194/ima unidirectional prepreg/product/Hexcel Corporation
Average 90 stars, based on 1 article reviews
m21/ud194/ima unidirectional prepreg - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B ) K562R-ima, and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).

Journal: Biomolecules

Article Title: Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells

doi: 10.3390/biom15091245

Figure Lengend Snippet: Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B ) K562R-ima, and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).

Article Snippet: Later, the 5 μM resistant K562R cell line was produced by gradually increasing the IMA (Santa Cruz, Dallas, TX, USA) concentration over a period of 18 months using the K562R 0.6 cells as the starting population [ ].

Techniques:

Protein levels of ITGA2 were analyzed by flow cytometry. Columns indicate mean fluorescence intensity in ( A ) K562S; ( B ) K562R-ima; ( C ) K562R+ima. ( n = 4) (*** p < 0.001 and **** p < 0.0001).

Journal: Biomolecules

Article Title: Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells

doi: 10.3390/biom15091245

Figure Lengend Snippet: Protein levels of ITGA2 were analyzed by flow cytometry. Columns indicate mean fluorescence intensity in ( A ) K562S; ( B ) K562R-ima; ( C ) K562R+ima. ( n = 4) (*** p < 0.001 and **** p < 0.0001).

Article Snippet: Later, the 5 μM resistant K562R cell line was produced by gradually increasing the IMA (Santa Cruz, Dallas, TX, USA) concentration over a period of 18 months using the K562R 0.6 cells as the starting population [ ].

Techniques: Flow Cytometry, Fluorescence

Flow cytometric analysis using Annexin V-PE/7-AAD-stained K562S and K562R cells. Quantification of apoptotic populations (bar graph) in ( A ) K562S; ( B ) K562R-ima; ( C ) K562R+ima cells; ( D ) Dot plot representation of flow cytometry data. ( n = 4) (** p < 0.01, and **** p < 0.0001).

Journal: Biomolecules

Article Title: Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells

doi: 10.3390/biom15091245

Figure Lengend Snippet: Flow cytometric analysis using Annexin V-PE/7-AAD-stained K562S and K562R cells. Quantification of apoptotic populations (bar graph) in ( A ) K562S; ( B ) K562R-ima; ( C ) K562R+ima cells; ( D ) Dot plot representation of flow cytometry data. ( n = 4) (** p < 0.01, and **** p < 0.0001).

Article Snippet: Later, the 5 μM resistant K562R cell line was produced by gradually increasing the IMA (Santa Cruz, Dallas, TX, USA) concentration over a period of 18 months using the K562R 0.6 cells as the starting population [ ].

Techniques: Staining, Flow Cytometry

Effects of E7820 (2.5 μM) on caspase3/7 activity in treated K562S and K562R cells compared to their untreated counterparts. ( A ) K562S; ( B ) K562R-ima; ( C ) K562R+ima cells ( n = 4) (** p < 0.01 and **** p < 0.0001).

Journal: Biomolecules

Article Title: Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells

doi: 10.3390/biom15091245

Figure Lengend Snippet: Effects of E7820 (2.5 μM) on caspase3/7 activity in treated K562S and K562R cells compared to their untreated counterparts. ( A ) K562S; ( B ) K562R-ima; ( C ) K562R+ima cells ( n = 4) (** p < 0.01 and **** p < 0.0001).

Article Snippet: Later, the 5 μM resistant K562R cell line was produced by gradually increasing the IMA (Santa Cruz, Dallas, TX, USA) concentration over a period of 18 months using the K562R 0.6 cells as the starting population [ ].

Techniques: Activity Assay

Gene expression analysis of K562S and K562R cells upon incubation with E7820 for 72 h by real-time PCR assay. Effects of E7820 treatment BAX , BAD , BIM , and BCL-2 gene expressions; ( A ) K562S; ( B ) K562R-ima; ( C ) K562R+ima cell; ( D ) Bar graph presentation of BAX/BCL-2 mRNA ratio. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).

Journal: Biomolecules

Article Title: Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells

doi: 10.3390/biom15091245

Figure Lengend Snippet: Gene expression analysis of K562S and K562R cells upon incubation with E7820 for 72 h by real-time PCR assay. Effects of E7820 treatment BAX , BAD , BIM , and BCL-2 gene expressions; ( A ) K562S; ( B ) K562R-ima; ( C ) K562R+ima cell; ( D ) Bar graph presentation of BAX/BCL-2 mRNA ratio. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).

Article Snippet: Later, the 5 μM resistant K562R cell line was produced by gradually increasing the IMA (Santa Cruz, Dallas, TX, USA) concentration over a period of 18 months using the K562R 0.6 cells as the starting population [ ].

Techniques: Gene Expression, Incubation, Real-time Polymerase Chain Reaction

Intracellular accumulation of Rho-123 was assessed by flow cytometry in K562S, K562R-ima, and K562R+ima cells. ( A ) Flow cytometry results are represented as dot; ( B ) Bar graph representation of flow cytometry data. ( n = 4) (**** p < 0.0001).

Journal: Biomolecules

Article Title: Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells

doi: 10.3390/biom15091245

Figure Lengend Snippet: Intracellular accumulation of Rho-123 was assessed by flow cytometry in K562S, K562R-ima, and K562R+ima cells. ( A ) Flow cytometry results are represented as dot; ( B ) Bar graph representation of flow cytometry data. ( n = 4) (**** p < 0.0001).

Article Snippet: Later, the 5 μM resistant K562R cell line was produced by gradually increasing the IMA (Santa Cruz, Dallas, TX, USA) concentration over a period of 18 months using the K562R 0.6 cells as the starting population [ ].

Techniques: Flow Cytometry